Peripheral T-cell lymphomas (PTCLs) represent approximately 12% of all lymphoid tumors worldwide. The vast majority of them belong to the not otherwise specified (NOS) angioimmunoblastic or ...

In other words, transient CAR-mediated CD4 + depletion would be used as a short-term 'bridge to transplant ... PTCLs and other T-cell malignancies. Human lymphoma cells and peripheral blood ...

Peripheral T-cell lymphoma (PTCL) is an aggressive tumor derived from mature T cells and natural killer cells with an extremely poor prognosis. Ferroptosis is a mechanism of cell death that is ...

On this World Cancer Day, Chris Vogelsang, a cancer survivor from upstate New York, is celebrating his recovery thanks to a ...

Results of 3 trials revealed that omitting transplant did not impact progression or survival outcomes for pediatric, ...

Other lymphomas, such as peripheral T-cell lymphoma ... and stem cell transplant. Some forms of T-cell lymphoma, especially if it is slow growing, may not receive any treatment.

Peripheral T-cell lymphomas (PTCLs ... particularly in angioimmunoblastic T-cell lymphoma (AITL). CD28 is the major co-stimulatory receptor in T cells which, upon binding ligand, induces sustained ...

Immunotherapy aims to enhance the body's immune system to recognize and attack cancer cells. Types of immunotherapy used to treat stage 4 lymphoma include: CAR T-Cell Therapy This is a type of ...

including T cell lymphomas, cutaneous (skin) lymphomas, Hodgkin disease, and lymphomas in immunosuppressed patients after organ transplant (post-transplant lymphoproliferative disorders or PTLD). My ...

Ann LaCasce, MD, MMSc, delved into some of the most recent advances in the lymphoma space, exploring how these new therapies ...

My particular expertise is in the area of allogeneic transplantation — the use of stem cells or bone marrow derived from a donor other than the patient. Stem cells can come from different sources ...